Tai Chi vs Qi-Gong for early-stage Parkinson’s patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares Tai Chi therapy to Qi-Gong in individuals with stage-I Parkinson’s disease over 8 to 12 weeks. Participants will be adults 50–65 on stable Parkinson’s medications and with adequate cognitive function. Outcomes will include motor function, postural control, and functional balance measured at baseline and after the intervention using standard scales. The study aims to determine which practice is more tolerable and effective for sustaining participation in neuromuscular rehabilitation. Results could support improved rehabilitation strategies and inform evidence-based physiotherapy practice for Parkinson’s disease.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of PD based on the Hoehn \& Yahr staging system (Stages I).
* Male or female patients aged between 50-65 years.
* Currently receiving stable anti-Parkinsonian medication, with no changes in the treatment regimen for at least 3 months.
* Basic self-care ability with no severe cognitive impairment (Mini-Mental State Examination \[MMSE\] score ≥24).

Exclusion Criteria:

* Depression, as assessed based on a score of \>16 for the Beck Depression Inventory-II (BDI-II).
* Recent deep brain stimulation (DBS) treatment.
* Use of medication that interferes with cognition, alertness, or attention.
* Current participation in an exercise training program.

Where it's running

• Ghurki Trust and Teaching Hospital
  Lahore, Punjab Province, Pakistan Recruiting
• The Meer's Physiotherapy and Rehabilitation
  Lahore, Pakistan Recruiting

Study contacts

• Study coordinator: Maryam Fayyaz
• Email: maryamfayyazawan@gmail.com
• Phone: 03374677916

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• UX-DA003 injections for Parkinson's disease

  This early-phase trial tests whether injecting UX-DA003 is safe and may help motor symptoms in people with Parkinson's whose response to standard treatments has declined.

  Recruiting Early Phase 1 The First Affiliated Hospital of Anhui Medical University · Hefei, Anhui · NCT07911670

• Strength and dual-task training to help people with Parkinson’s improve strength and function

  This trial tests three levels of physiotherapy, including progressive resistance training with and without cognitive dual-task and instability components, to see if they improve muscle strength, body composition, and physical function in adults with Parkinson’s or related syndromes.

  Recruiting University of Valencia · Valencia, Valencia · NCT07907302

• Spinal Mobility, Rigidity, and Kinesiophobia in Parkinson's Disease with and without TMD

  This study tests whether people with Parkinson's disease who have Temporomandibular Disorders differ in spinal mobility, axial rigidity, and kinesiophobia from those without TMD.

  Recruiting Mustafa Kemal University · Hatay · NCT07850674

• A 12-Week Trial of Flexilev with the OraFID Device and App for Parkinson's

  This study tests whether taking small, precise doses of Flexilev with the OraFID dosing device and Levilog app is acceptable and helps people with Parkinson's manage their medicine.

  Recruiting at 2 sites Phase 4 Navamedic AB · Stockholm, Stockholm County and 4 other locations · NCT07839793

• Integrated Motor-Cognitive Training in Parkinson's Disease

  This study tests a combined motor and cognitive rehabilitation program to see if people with Parkinson’s disease can stick with it and show early signs of benefit.

  Recruiting University Hospital of Ferrara · Ferrara, FE · NCT07833748

• VIM0423 for Parkinson's Tremor in Adults Not Fully Controlled by Dopaminergic Therapy

  A Vima Therapeutics study tests whether the oral drug VIM0423 can reduce tremor in adults with Parkinson’s disease who still have tremor despite dopaminergic treatment.

  Recruiting at 4 sites Phase 2 Vima Therapeutics · Scottsdale, Arizona and 29 other locations · NCT07804615

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.